![](/img/cover-not-exists.png)
Mild-to-moderate benign prostatic hyperplasia symptoms: Filling the gap. Efficacy and safety of Afalaza in men with benign prostatic hyperplasia at risk of progression: A multicenter, double-blind, placebo-controlled, randomized clinical trial
Vinarov, A.Z., Pushkar, D., Spivak, L.Volume:
18
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)30186-1
Date:
March, 2019
File:
PDF, 87 KB
english, 2019